Filing Details
- Accession Number:
- 0001209191-21-055504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:25:48
- Reporting Period:
- 2021-07-01
- Accepted Time:
- 2021-09-10 17:25:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-01 | 15 | $2.91 | 5,768,529 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-02 | 15 | $2.94 | 5,768,544 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-06 | 15 | $3.14 | 5,768,559 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-07 | 15 | $3.21 | 5,768,574 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-08 | 15 | $3.18 | 5,768,589 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-09 | 15 | $3.13 | 5,768,604 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-12 | 15 | $3.33 | 5,768,619 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-13 | 15 | $3.48 | 5,768,634 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-14 | 15 | $3.33 | 5,768,649 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-15 | 15 | $3.27 | 5,768,664 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-16 | 15 | $3.28 | 5,768,679 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-19 | 15 | $3.23 | 5,768,694 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-20 | 15 | $3.24 | 5,768,709 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-21 | 15 | $3.26 | 5,768,724 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-22 | 15 | $3.36 | 5,768,739 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-23 | 15 | $3.35 | 5,768,754 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-26 | 15 | $3.41 | 5,768,769 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-27 | 15 | $3.39 | 5,768,784 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-28 | 15 | $3.42 | 5,768,799 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-29 | 15 | $3.42 | 5,768,814 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-07-30 | 15 | $3.31 | 5,768,829 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
